top of page

Repeat Dosing of Psilocybin in Migraine Headache

About the study

NCT Trial Number

NCT04218539

The drug being studied

Psilocybin

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Yale University
Wallace Research Foundation

noun_date_3237048.png

Trial Start Date

Jul-20

noun_capsule_138144.png

About the participants

Age seeking

21 Years to 65 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Migraine Headache

noun_square_138133.png

Accepts healthy volunteers?

No

This study will investigate single and repeated dosing of psilocybin up to two doses. The study aims to explore the underlying mechanism in psilocybin's effects on migraine headaches.

Eyes Graffiti

Locations

United States
Yale University
Wallace Research Foundation

Contact: Taylor Flynn, BS
203-932-5711 ext 2557
leigh.flynn@yale.edu

Contact: Emmanuelle Schindler, MD PhD
203-932-5711 ext 4335
emmanuelle.schindler@yale.edu

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page